A new report indicates that U.S. drugmakers will raise prices on at least 350 medications despite pressure from President ...
Hosted on MSN
Trump promises cheaper drugs under TrumpRx, but economists say the long-term costs may be hidden
As President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists are raising questions about what happens when prices are capped and whether short-term savings for ...
Countries like Spain have used 'most-favored-nation' drug pricing for decades. While it may reduce the cost of drugs, it will ...
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
Competition to create new brand-name drugs is a key driver of innovation in the United States. Unfortunately, it also drives the relentless growth of healthcare spending. That’s because development of ...
HHS Secretary Robert F. Kennedy Jr., FDA Commissioner Marty Makary, MD, and CMS Administrator Mehmet Oz, MD, announced new FDA guidance aimed at making biosimilar drug development faster and less ...
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Drug companies launched an ad and publicity extravaganza this year right after President-elect Donald Trump said they "are getting away with murder" on sky-high pill prices. More than it has in years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results